Aventusoft L.l.c
Boca Raton, FL
- UEI
- LX1DCB3LCT87
- CAGE
- 5GZ65
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- 3651 FAU Boulevard #300, Boca Raton, FL 33431, USA
- Website
- aventusoft.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Capital Goods
- Construction & Engineering
- SIC code
- 76 Miscellaneous Repair Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase I tasking | Medical Command (Army) | $149,986 | |
| Status report | Naval Sea Systems Command (Navy) | $80,000 | |
| Sbir 9.2 phase II - title: "acoustic source separation and localization" | Interior Business Center (DO) | $749,956 | |
| DARPA sbir phase I | Aviation and Missile Command (AMC) | $98,816 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Aventusoft LLC, a Boca Raton, Florida-based minority-owned and self-certified small disadvantaged business, develops wearable biosensor and mobile health devices for non-invasive cardiac and physiological monitoring, funded exclusively through federal research grants as a recipient under the Small Business Innovation Research (SBIR) program. The company is 100% grant-funded with no federal contract prime awards or contract vehicles and holds Subcontinent Asian (Asian-Indian) American ownership designation.
Aventusoft's federal footprint centers on the National Heart, Lung, and Blood Institute (NHLBI), which has funded five awards totaling the largest share of the company's research portfolio. The National Science Foundation and the broader National Institutes of Health have each provided three grants. The Defense Advanced Research Projects Agency and the Department of the Army Medical Command round out the customer set. The company's technology pipeline spans three named hemodynamic and physiological monitoring products in active development: HEMOLINK, a skin-adhered patch for non-invasive left ventricular end-diastolic pressure (LVEDP) monitoring awarded $500,000 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837); HATS-OFF (HemotTag Assessment for Short-Term Outcomes of Heart Failure), a home-based hemodynamic monitoring device that demonstrated statistically significant reductions in hospitalizations in Phase II trials, awarded $500,000 on July 15, 2025, under the Cardiovascular Diseases Research program; and PAINVITALS, an AI-powered wearable biosensor for continuous pain monitoring awarded by the National Institute of General Medical Sciences on September 5, 2025. Additional prior work includes an SBIR Fast-Track project awarded April 1, 2023, for a mobile health framework enabling LVEDP diagnostics via smartphone.
Recent grant activity has been episodic — one award in 2020, one in 2021, one in 2023, two in 2025, and one in 2026 — with two grants carrying ultimate completion dates within the next twenty-four months. Combined obligated dollars ($32.5 million) far exceed combined potential value ($1.1 million), reflecting mature research completion phases where obligations have accrued ahead of the stated ceiling. Work is performed in Boca Raton, Florida, with clinical validation conducted in collaboration with large healthcare systems in Florida.
Quick answers
Is Aventusoft L.l.c registered in SAM.gov?
Yes. Aventusoft L.l.c's SAM.gov registration is active through November 10, 2026.
What is Aventusoft L.l.c's CAGE code?
Aventusoft L.l.c's CAGE code is 5GZ65, and its Unique Entity ID (UEI) is LX1DCB3LCT87.
What is Aventusoft L.l.c's most recent federal award?
Aventusoft L.l.c's most recent federal grant award is Commercialization readiness pilot program support for: hemolink - 7. Project summary/abstract cardiovascular disease… (SB1HL184385), from National Heart Lung and Blood Institute (NIH), on September 1, 2026.
On GovTribe
See Aventusoft L.l.c's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors